 |
Strontium Oxide
SrO 1314-11-0
|
| Product |
Product Code |
Order or Specifications |
99% Strontium Oxide |
|
 |
99.9% Strontium Oxide |
SR-OX-03 |
 |
99.99% Strontium Oxide |
SR-OX-04 |
 |
99.999% Strontium Oxide |
|
 |
|
Strontium Oxide is
a highly insoluble thermally stable Strontium source suitable for glass, optic and ceramic applications. Oxide compounds are not conductive to electricity. However, certain perovskite structured oxides are electronically conductive finding application in the cathode of solid oxide fuel cells and oxygen generation systems. They are compounds containing at least one oxygen anion and one metallic cation. They are typically insoluble in aqueous solutions (water) and extremely stable making them useful in ceramic structures as simple as producing clay bowls to advanced electronics and in light weight structural components in aerospace and electrochemical applications such as fuel cells in which they exhibit ionic conductivity. Metal oxide compounds are basic anhydrides and can therefore react with acids and with strong reducing agents in redox reactions. Strontium Oxide is also available in pellets, pieces, sputtering targets, tablets, and nanopowder (from American Elements' nanoscale production facilities).
See Nanotechnology for more nanotechnology applications information. Strontium Oxide is generally immediately available in most volumes. Ultra high purity, high purity, submicron and nanopowder forms may be considered. Additional technical, research and safety (MSDS) information is available.
Strontium is a Block S, Group 2, Period 5 element. The electronic configuration is [Kr] 5s2. In its elemental form strontium's CAS number is 7440-24-6. The strontium atom has a radius of 215.1.pm and it's Van der Waals radius is 200.pm. Strontium has low tech applications as an additive to flares and pyrotechnics because of the bright crimson flame produced by its salts. Strontium is available as metal and compounds with purities from 99% to 99.999% (ACS grade to ultra-high purity); metals in the form of foil, sputtering target, and rod, and compounds as submicron and nanopowder. It also has many high technology applications because of its high refractive index as a titanate in glass, as a "getter" in electron tubes and as a dopant for numerous perovskite formulations to produce cathodes for oxygen generation or solid oxide fuel cells. |
| Formula |
CAS No. |
Appearance |
Molecular Weight |
Density |
Melting Point |
Boiling Point |
| SrO |
1314-11-0 |
White Crystalline Solid |
103.619 |
5100 kg/m-3 |
2530 °C; 2665°C |
3000 °C |
|
|
© 2001-2008. American Elements is a U.S. Registered Trademark. All rights reserved.
This website and all pages, designs, concepts, logos, and color schemes herein are
the copyrighted proprietary rights and intellectual property of American Elements. |
|
|
Recent Research & Development for Strontium
-
Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: Results of a five-year, randomized, placebo-controlled trial.
Arthritis Rheum. 2008 May 31;58(6):1687-1695. [Epub ahead of print]
-
Structural analysis of a series of strontium-substituted apatites.
Acta Biomater. 2008 May 3. [Epub ahead of print]
-
Plutonium, (137)Cs and (90)Sr in selected invertebrates from some areas around Chernobyl nuclear power plant.
J Environ Radioact. 2008 May 23. [Epub ahead of print]
-
Cooperative Binding of Phosphate Anion and a Neutral Nitrogen Donor to Alkaline-Earth Metal Ions. Investigation of Group 2 Metal-Organophosphate Interaction in the Absence and Presence of 1,10-Phenanthroline.
Inorg Chem. 2008 May 24. [Epub ahead of print]
-
A Reactivity Change of a Strontium Monohydroxide by Umpolung to an Acid.
Inorg Chem. 2008 May 23. [Epub ahead of print]
-
Application of inductively coupled plasma-mass spectrometry (ICP-MS) and quality assurance to study the incorporation of strontium into bone, bone marrow, and teeth of dogs after one month of treatment with strontium malonate.
Anal Bioanal Chem. 2008 May 23. [Epub ahead of print]
-
A Monte Carlo model of an industrial gauge for radiation protection purposes.
Australas Phys Eng Sci Med. 2008 Mar;31(1):42-8.
-
Adsorption and Diffusion Parameters of Methane and Nitrogen on Microwave-Synthesized ETS-4.
Langmuir. 2008 May 17. [Epub ahead of print]
-
Aminotroponiminate calcium and strontium complexes.
Dalton Trans. 2008 Jun 7;(21):2839-2843. Epub 2008 Apr 4.
-
Effects of Dyract AP and released ionic products on periodontal ligament cells and bone marrow cultures.
Dent Mater. 2008 May 7. [Epub ahead of print]
-
Microwave properties of polymer composites containing combinations of micro- and nano-sized magnetic fillers.
J Nanosci Nanotechnol. 2008 Feb;8(2):650-4.
-
Workplace performance of a hood-style supplied-air respirator.
J Occup Environ Hyg. 2008 Jul;5(7):438-43.
-
Metal Concentrations in Plasma and Cerebrospinal Fluid in Patients with Alzheimer's Disease.
Dement Geriatr Cogn Disord. 2008 May 5;25(6):508-515. [Epub ahead of print]
-
Developments in Heterobimetallic s-Block Systems: Synthesis and Structural Survey of Molecular M/Ae (M = Li, Na, K, Cs; Ae = Ca, Sr) Aryloxo Complexes.
Inorg Chem. 2008 Jun 2;47(11):4669-81. Epub 2008 May 7.
-
Unlocking evidence of early diet from tooth enamel.
Proc Natl Acad Sci U S A. 2008 May 13;105(19):6834-9. Epub 2008 May 5.
-
Effects of alkaline earth metal ion complexation on amino acid zwitterion stability: results from infrared action spectroscopy.
J Am Chem Soc. 2008 May 21;130(20):6463-71. Epub 2008 Apr 29.
-
Reconstruction of (90)Sr intake for breast-fed infants in the Techa riverside settlements.
Radiat Environ Biophys. 2008 Apr 29. [Epub ahead of print]
-
Interaction of Sr-doped hydroxyapatite nanocrystals with osteoclast and osteoblast-like cells.
J Biomed Mater Res A. 2008 Apr 24. [Epub ahead of print]
-
[Native or not? Isotope analysis of a female skeleton on the 9th century A.D. from Elsau, Canton Zurich, Switzerland]
Anthropol Anz. 2008 Mar;66(1):19-50. German.
-
Pharmacological topics of bone metabolism: recent advances in pharmacological management of osteoporosis.
J Pharmacol Sci. 2008 Apr;106(4):530-5.
|
|